Transcriptomics

Dataset Information

0

The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity


ABSTRACT: Type I Interferons (IFN-I) stimulate pro-inflammatory programs critical for immune activation, but also induce immune-suppressive feedback circuits that contribute to the failure of cancer control. Yet, how IFN-Is differentially induce these opposing programs remains enigmatic. We establish that the transcription factor Interferon Regulatory Factor 2 (IRF2) is a central feedback molecule attenuating IFN signaling and driving CD8 T cell exhaustion in the tumor microenvironment. IRF2 inhibits CD8 T cell effector function in response to sustained interferon signaling by programming T cell exhaustion. Lineage-specific deletion of IRF2 limits CD8 T cells exhaustion to maintain effector functions, thereby enabling long-term tumor control, and increased responsiveness to immune-checkpoint and adoptive cell therapies. Long-term tumor control by IRF2-deficient CD8 T cells is dependent on continuous integration of both IFN-I and IFN? signals, which in the absence of IRF2, potentiate sustained effector function instead of exhaustion. Thus, IRF2 redirects IFN signalling to drive T cell exhaustion and prevent tumor control.

ORGANISM(S): Mus musculus

PROVIDER: GSE199177 | GEO | 2022/11/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-11-16 | GSE212697 | GEO
2022-11-16 | GSE212699 | GEO
2022-11-16 | GSE212698 | GEO
2019-01-10 | GSE114631 | GEO
2015-02-13 | E-GEOD-64407 | biostudies-arrayexpress
2015-02-13 | E-GEOD-64408 | biostudies-arrayexpress
2022-10-10 | GSE180094 | GEO
2022-04-26 | GSE201073 | GEO
2022-04-26 | GSE201072 | GEO
2022-04-26 | GSE201071 | GEO